Markets

Ariad Pharmaceuticals (ARIA) in Focus: Stock Up 5.3%

Ariad Pharmaceuticals Inc.(ARIA) was a big mover last session, as the company saw its shares rise above 5% on the day. The upside came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend since Aug 31, as the stock is now down almost 18%.

In the last 30 days, the company has seen one downward estimate revisions and the Zacks Consensus Estimate moved lower, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

Ariad Pharmaceuticals carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

A better-ranked MED-Drugs stock is Alcobra Ltd. (ADHD) , which sports a Zacks Rank #1 (Strong Buy).

Is ARIA going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ARIAD PHARMA (ARIA): Free Stock Analysis Report

ALCOBRA LTD (ADHD): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos